SCM
KZR

Sio Capital Management’s Kezar Life Sciences KZR Stock Holding History

Sio Capital Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-917
Closed -$152K – 68
2022
Q1 		$152K Sell
917
-20,408
-96% -$2.93M 0.05% 62
2021
Q4 		$3.56M Buy
+21,325
New +$2.41M 1.07% 25

Other funds holding KZR

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sio Capital Management's KZR Position: Q2 2022 in Review

Sio Capital Management sold out of Kezar Life Sciences (KZR) in Q2 2022, closing a stake of 917 shares — an estimated $152K sold.

Sio Capital Management first reported a position in KZR in Q4 2021 and held it in 2 quarters. The position peaked at $3.56M in Q4 2021. 127 funds tracked by Wall St. Rank hold KZR as of Q2 2022.

  • Sio Capital Management reported no remaining Kezar Life Sciences position as of Q2 2022 after selling out during the quarter.
  • Sio Capital Management sold 917 Kezar Life Sciences shares in Q2 2022, an estimated $152K.
  • Sio Capital Management first reported a position in Kezar Life Sciences in Q4 2021 and held it in 2 quarters.
  • Sio Capital Management's Kezar Life Sciences position peaked at $3.56M in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2022.

Based on Sio Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.